GHK-CU
Overview
Research-use copper tripeptide complex supplied for studies of extracellular-matrix remodeling, redox balance, and cellular repair pathway models.
- Concentration
- 50 mg / 100 mg
- Stock
- In stock
Product details
GHK-Cu is a copper-complexed tripeptide used in research models of matrix remodeling and redox signaling. Pattern lists this material for controlled laboratory research.
Research Targets: Extracellular-matrix signaling, copper-associated redox pathways, collagen and glycosaminoglycan synthesis models.
Key Feature: Gly-His-Lys tripeptide complexed with copper for metallopeptide research.
Research Focus Areas: Dermal fibroblast models, matrix turnover, collagen organization, oxidative-stress response studies.
Common Models: Skin fibroblast cultures, tissue explant assays, extracellular-matrix remodeling studies.
Mechanistic Interests: Copper-dependent redox balance, metalloproteinase signaling, gene-expression markers in cellular repair pathways.
Use Boundary: Research use only; not for human or veterinary use; no diagnostic, therapeutic, or consumption use is implied.
Research context
Peptide guide
Open full guide- Guide profile
- Copper Tripeptide-1
- Composition
- Naturally occurring tripeptide complexed with copper ions (Glycyl-L-Histidyl-L-Lysine Copper), found in human plasma, saliva, and urine
- Discovery
- Discovered in 1973 by Dr. Loren Pickart while studying human plasma factors that could restore youthful function to aged liver tissue
- Research scope
- Extensive preclinical studies (in vitro, animal models) and some human clinical data support GHK-Cu's effects, particularly in skin applications
- Regulatory status
- Not FDA-approved for therapeutic use; cosmetic and dermatologic research is more developed than systemic wellness claims
Safety context
- Copper sensitivities or conditions like Wilson's disease should avoid it
- Limited major regulatory approval for medical treatment
- Caution is appropriate when copper metabolism is abnormal or poorly characterized
Research-use notice: GHK-Cu has its clearest evidence base in skin and wound-repair research, while systemic wellness and aging claims are less established. It lacks major regulatory approval for medical treatment, and clinical decisions require qualified medical oversight.
Full guide includes 10 reference entries.
